Dermatology Specialists, Louisville Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2007
NCT00509275
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Dermatology Specialists, 501 South Second Street, Louisville, KY 40202, US

Active Ingredients

Drugs in Phase 1 Trials (1)

dexbrompheniramine (disomer) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tinea (Phase 1)

Tinea Pedis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1